β-lactamase inhibitors
US11980631B2 · kind B2 · utility
0Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 18, 2018 |
| Grant date | May 14, 2024 |
| Priority date | — |
| Expiry date | May 18, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of certain β-lactamase inhibitors in conjunction with one or more ⊕-lactam antibiotics for the treatment of Strenotrophomonas maltophilia, tuberculosis or Pseudomonas species infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.